Lu, Jinxin
Zhang, Xiaoyu
Su, Keyu
Luo, Huandong
Liu, Congcong
Yang, Yuqing
He, Bin
Wang, Cenxin
Zhao, Zhuoran
Liu, Xianxian
Wang, Xu
Meng, Peixuan
Lv, Dekang
Wang, Chunli
Kelley, Keith W.
Wang, Ling
Cui, Bai
Liu, Quentin
Peng, Fei
Funding for this research was provided by:
Wu Jieping Medical Foundation (2023HZ060)
National Natural Science Foundation of China (No. 82373096)
National Natural Science Foundation of China (No. 82273480)
National Key Research and Development Program of China (2022YFA1104002)
Article History
Received: 13 June 2024
Accepted: 12 July 2024
First Online: 25 July 2024
Change Date: 13 July 2026
Change Type: Update
Change Details: The original online version of this article was revised: authors would like to update Figure 5A which was misplaced since it didn’t belong to the indicated group
Change Date: 15 July 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12964-026-03056-y
Declarations
Ethics approval and consent to participate: All animal studies were conducted in accordance with Dalian Medical University’s guidelines for animal care and approved by the Institutional Animal Care and Use Committee (IACUC) of Dalian Medical University (AEE18018). Human lung cancer tissues and adjacent normal tissues used in the western blot were obtained from the patients undergoing surgery, as approved by the First Affiliated Hospital of Dalian Medical University (No. PJ-KS-KY-2023-137). All patients provided written informed consent.
Consent for publication: All authors consent to the publication of this article.
Competing interests: The authors declare no competing interests.